| pubmed-article:16515241 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16515241 | lifeskim:mentions | umls-concept:C1123023 | lld:lifeskim |
| pubmed-article:16515241 | lifeskim:mentions | umls-concept:C0039736 | lld:lifeskim |
| pubmed-article:16515241 | lifeskim:mentions | umls-concept:C0867389 | lld:lifeskim |
| pubmed-article:16515241 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:16515241 | lifeskim:mentions | umls-concept:C0205231 | lld:lifeskim |
| pubmed-article:16515241 | pubmed:dateCreated | 2006-3-6 | lld:pubmed |
| pubmed-article:16515241 | pubmed:abstractText | Thirty years female underwent allogenic peripheral blood stem cell transplantation for chronic myeloid leukaemia--chronic phase. She developed grade II acute skin graft-versus-host disease (GVHD) which was treated with cyclosporine and a short course of steroids. She developed extensive chronic GVHD of the skin and liver three hundred days post-transplant. She was managed with the standard immunosuppressants with partial response of liver dysfunction but no response of skin lesions. She showed a good response to therapy with resolution of skin lesions after treatment with thalidomide. | lld:pubmed |
| pubmed-article:16515241 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16515241 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16515241 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16515241 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16515241 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16515241 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16515241 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16515241 | pubmed:issn | 0004-5772 | lld:pubmed |
| pubmed-article:16515241 | pubmed:author | pubmed-author:NairVV | lld:pubmed |
| pubmed-article:16515241 | pubmed:author | pubmed-author:AroraSS | lld:pubmed |
| pubmed-article:16515241 | pubmed:author | pubmed-author:SharmaAA | lld:pubmed |
| pubmed-article:16515241 | pubmed:author | pubmed-author:GhoshII | lld:pubmed |
| pubmed-article:16515241 | pubmed:author | pubmed-author:SahaiKavitaK | lld:pubmed |
| pubmed-article:16515241 | pubmed:author | pubmed-author:DuttaVibhaV | lld:pubmed |
| pubmed-article:16515241 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16515241 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:16515241 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16515241 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16515241 | pubmed:pagination | 988-90 | lld:pubmed |
| pubmed-article:16515241 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:meshHeading | pubmed-meshheading:16515241... | lld:pubmed |
| pubmed-article:16515241 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16515241 | pubmed:articleTitle | Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide. | lld:pubmed |
| pubmed-article:16515241 | pubmed:affiliation | Army Hospital (R & R), Delhi Cantt, New Delhi. | lld:pubmed |
| pubmed-article:16515241 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16515241 | pubmed:publicationType | Case Reports | lld:pubmed |
